Noa Biran, MD, discusses her thoughts on the promising combination of carfilzomib and daratumumab in revlimid-refractory multiple myeloma patients at the 2018 Annual Meeting.
Thoughts on combination carfilzomib & daratumumab in revlimid-refractory multiple myeloma
